Cat Eye Syndrome Chromosome Region Candidate 1 (CECR1), also known as Adenosine Deaminase 2 (ADA2), is a gene located on chromosome 22q11.1. This gene is implicated in Cat Eye Syndrome (CES), a rare genetic disorder characterized by a variety of congenital anomalies. The recombinant form of CECR1 is produced through recombinant DNA technology, which allows for the expression of the human gene in a host organism, typically bacteria or yeast, to produce the protein in large quantities.
Cat Eye Syndrome is named for the characteristic eye appearance in some affected individuals, which resembles a cat’s eye due to a coloboma of the iris. The syndrome is caused by the presence of an extra chromosome fragment, specifically a small supernumerary marker chromosome derived from chromosome 22 . This extra genetic material leads to a wide range of symptoms, including ocular, cardiac, renal, and anal anomalies .
The CECR1 gene encodes the enzyme adenosine deaminase 2 (ADA2), which is involved in the degradation of extracellular adenosine. Adenosine acts as a signaling molecule in various cellular processes, including inflammation and immune response . Mutations or alterations in the CECR1 gene can disrupt these processes, contributing to the symptoms observed in Cat Eye Syndrome.
The recombinant form of CECR1 is produced using recombinant DNA technology. The process involves the following steps:
The ADA2 enzyme catalyzes the deamination of adenosine to inosine, a crucial step in purine metabolism. This reaction involves the removal of an amino group from adenosine, resulting in the formation of inosine and ammonia. The activity of ADA2 is essential for maintaining the balance of adenosine levels in the extracellular space, which in turn regulates various physiological processes .